Another player entered the arena in the running saga over Allergan (NYSE:AGN) as hedge fund Paulson & Co bought up a huge chunk of the Botox-maker’s shares, according to Reuters.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice